- Global Pharma News & Resources

Press Releases - 2021-05-11

Date Title Company
11-May-2021 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Skillz Inc. f/k/a Flying Eagle Acquisition Corp. (SKLZ) on Behalf of Investors Businesswire
11-May-2021 CORRECTING and REPLACING Former FDA and NIH Leader Dr. Vicki Seyfert-Margolis Joins Penrose TherapeuTx Scientific Advisory Board Businesswire
11-May-2021 Business and Policy Leaders Sign Letter to President Biden Urging U.S. Leadership to Speed Global Vaccination Effort Businesswire
11-May-2021 NANOBIOTIX Partners With LianBio to Develop and Commercialize Potential First-in-Class Radioenhancer NBTXR3 Across Tumor Types and Therapeutic Combinations in China and Other Asian Markets Businesswire
11-May-2021 Ipsen exerce son option de licence et rejoint Exelixis dans le développement de Cabometyx® pour les patients atteints de cancer de la thyroïde, sur la base de résultats intermédiaires prometteurs Businesswire
11-May-2021 Ipsen Opts-in to Join Exelixis With Ongoing Development of Cabometyx® for People Living With a Form of Thyroid Cancer, Based on Promising Interim Results Businesswire
11-May-2021 Eagle Pharmaceuticals to Present at the 2021 RBC Capital Markets Global Healthcare Conference Businesswire
11-May-2021 SQZ Biotechnologies Reports First Quarter 2021 Financial Results and Recent Business Highlights Businesswire
11-May-2021 Labcorp and the U.S. Department of Health and Human Services Join Forces to Raise Awareness of COVID-19 Treatments Businesswire
11-May-2021 Graham Corporation Announces Fourth Quarter and Full Fiscal Year 2021 Financial Results Release and Conference Call Businesswire
11-May-2021 Paysign, Inc. Reports First-Quarter 2021 Financial Results Businesswire
11-May-2021 Electromed, Inc. Announces Fiscal 2021 Third Quarter Financial Results Businesswire
11-May-2021 Verastem Oncology Reports First Quarter 2021 Financial Results and Highlights Recent Company Progress Businesswire
11-May-2021 AbCellera to Present Virtually at Berenberg Conference on May 18, 2021 Businesswire
11-May-2021 MorphoSys and Incyte Announce First Patient Dosed in Phase 3 frontMIND Study Evaluating Tafasitamab Combination as a First-line Treatment for Diffuse Large B-Cell Lymphoma MorphoSys AG
11-May-2021 Biodesix Announces First Quarter 2021 Results Businesswire
11-May-2021 Cummins Elects Carla Harris to its Board of Directors Businesswire
11-May-2021 BISTel Showcases Smart Pharma Innovation Award Winner GrandView APM at 2021 Manufacturing Assets and Reliability Conference Businesswire
11-May-2021 X-Chem Announces OpenDEX DNA-Encoded Library Screening Businesswire
11-May-2021 Cartilage Hair Hypoplasia Market 2021 to Perceive Biggest Trend and Opportunity by 2028 CDN Newswire